Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BEWI – Results for the third quarter of 2024

Improved earnings for downstream in a market showing signs of recovery BEWI, a leading provider of packaging, components, and insulation solutions, today reports its results for the third quarter of 2024. The company recorded net sales of 252 million euro for the quarter, compared to 267 million euro for the same quarter of 2023. The adjusted EBITDA came in at 23 million euro, compared to 24 million euro for the third quarter of 2023. “We are pleased to see continued signs of recovery in the markets we operate. Interest rates have come down, and are expected to drop further, which is

DUG Foodtech announces the outcome of the rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR IN ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE ALSO SEE THE "IMPORTANT INFORMATION" SECTION BELOW. 6 November, 2024, Lund, Sverige   DUG Foodtech AB (publ) (“DUG Foodtech” or the “Company”) today announces the outcome of the rights issue

Noble Corporation plc Announces Third Quarter 2024 Results and Additional Share Repurchase Authorization

•          Closed Diamond acquisition on September 4th   •          Increased capital return program with additional share repurchase authorization of $400 million •          Repurchased 6.9 million of shares in Q3 2024, $0.50 per share dividend declared for Q4 2024, bringing total FY 2024 cash returns to shareholders to over $525 million, including Q4 dividend •          Q3 Net Income of $61 million, Diluted Earnings Per Share of $0.40, Adjusted EBITDA of $291 million, net cash provided by operating activities of $284 million, and Free Cash Flow of $165 million •          Q4

Noble Corporation plc Provides Guidance

SUGAR LAND, TEXAS, Nov. 5, 2024 /PRNewswire/ - Noble Corporation plc ("Noble") (CSE: NOBLE, NYSE: NE) today provides guidance for the quarter ended December 31, 2024. In accordance with Danish legal and stock exchange requirements, Noble announced that for the quarter ended December 31, 2024 guidance provided as follows: Total Revenue $850 to $890 million, Adjusted EBITDA $275 to $305 million, Capital Additions (net of reimbursements) $105 to $135 million. Noble is releasing its third quarter earnings simultaneously with this update. Please see the Third Quarter 2024 Earnings Release for

Nordea Bank Abp: Repurchase of own shares on 05.11.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares05.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 05.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |139,607|10.91 |1,523,238.

Odfjell SE 3Q24: Odfjell delivered another solid financial result

Odfjell SE today reported its results for the third quarter of 2024.Highlights: · Odfjell’s strong performance on safety continues with high operational efficiency and no significant incidents during the quarter. · Odfjell delivered another solid financial result in 3Q24, somewhat below record levels from previous quarter. · Freight rates remain healthy despite spot rates coming down during the quarter. Our volumes remain stable. · The time charter earnings in Odfjell Tankers ended at USD 202 million, compared to a record USD 215 million in 2Q24. · EBIT of USD 91 million

Nivika issues new senior unsecured green bonds of SEK 400 million

NOT FOR DISTRIBUTION IN OR TO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO PUBLISH OR DISTRIBUTE THIS PRESS RELEASENivika Fastigheter AB (publ) ("Nivika" or the "Company") has successfully issued senior unsecured green bonds in an initial amount of SEK 400 million under a total framework of SEK 800 million (the "Green Bonds" and the “Green Bond Issue”). The transaction received strong interest from Nordic institutional investors and

Relais Group Plc: Share Repurchase 5.11.2024

Relais Group Plc  ANNOUNCEMENT  5.11.2024 Relais Group Plc: Share Repurchase 5.11.2024 In the Helsinki Stock Exchange Trade date           5.11.2024Bourse trade         BuyShare                  RELAISAmount             70 SharesAverage price/ share    13,7000 EURTotal cost            959,00 EUR Relais Group Plc now holds a total of 71 785 sharesincluding the shares repurchased on 5.11.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

NKT secures extension of framework agreements for high-voltage power cables with RTE in France

NKT will deliver high-voltage power cable solutions to RTE to enable their long-term strategy to renew, adapt and develop France’s electricity grid. As one of Europe’s largest exporters of electricity, the upgrade of France’s grid is essential for the power supply of the continent.RTE, France’s Transmission System Operator (TSO), has awarded NKT the extension of two framework agreements for the supply of high-voltage power cables solutions from 2026 to 2028. The framework agreements are for onshore power cables, accessories and installation at voltage levels 90 kV, 225 kV and 400 kV. The

Redemption of Ordinary Shares and Total Voting Rights

Miton UK MicroCap Trust plc LEI: 21380048Q8UABVMAG916 5 November 2024   MITON UK MICROCAP TRUST PLC (the "Company")   Redemption of Ordinary Shares and Total Voting Rights   The Company has a redemption facility through which shareholders are entitled to request the redemption of all or part of their holding of ordinary shares of 0.1 pence each ("Ordinary Shares") on an annual basis (the "Redemption Facility"). The operation of the Redemption Facility is entirely at the discretion of the board of directors of the Company (the "Board"). The deadline for the 5

Buy-back of shares in MTG during week 44, 2024

During the period between 28 October and 1 November 2024 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 94,148 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors.The share buy-backs form a part of the share repurchase program of a maximum of 5,789,385 shares for a maximum amount of SEK 400 million, which MTG announced on 16 May 2024. The share repurchase program, which runs from 17 May 2024 up until and including 30 April 2025, is being carried out in accordance with the Market

Nytida acquires Friab's operations within individual and family care

Nytida, part of the Ambea Group, acquires the care provider Friab's operations in foster homes, HVB homes (homes for care or residence) and assisted living facilities.The operations included in the acquisition are units within foster home care, four HVB homes for children and youth, one HVB home for adults, three assisted living facilities, two daily activity units, one assisted living facility for care receivers with lesser care needs, and one supported living facility under contract management.   - The acquisition consists of high-quality operations that provide excellent care and

THOMSON IMPROVES ENERGY EFFICIENCY OF MEDIUM-DUTY APPLICATIONS WITH NEW 48-VOLT ELECTRIC LINEAR ACTUATOR

Editorial Contact: Shreyasi Bhaumik – +44 (0) 203 409 5090Company Contact: Kevin Bastian – +1 630 694 3342  Please quote the following contact information when publishing:Tel.: 540.633.3549, Fax: 540.633.0294, www.thomsonlinear.com; Thomson@regalrexnord.com11.05.2024, DOWNERS GROVE, IL – Thomson Industries, Inc., a leading manufacturer of linear motion control solutions, has announced that its Electrak® MD actuator now has a 48 V rating. The availability of a 48 V actuator that can handle loads of up to 2 kN (about 450 lbs.) equips battery powered system designers with energy

DanCann Pharma A/S: Capital reduction in DanCann Pharma A/S is completed

The capital reduction in DanCann Pharma A/S as resolved on an extraordinary general meeting held on 7 October 2024 has been completed today, 5 November 2024, following expiry of a 4-week notice period ("proklama").As set out in press release published on 7 October 2024, at an extraordinary general meeting in DanCann Pharma A/S held on 7 October 2024 it was resolved to reduce the share capital of the Company by nominally DKK 13,869,911.106 from nominally DKK 15,411,012.34 to nominally DKK 1,541,101.234 by transfer of the amount to a special reserve fund (in Danish: henlæggelse til særlig

Synsam invites you to a video presentation of the Q3 report 2024 and a live Q&A session

Synsam AB (publ) will release its interim report for the third quarter 2024 on Tuesday, November 19[th] at 07:30. At the same time, the company will publish an interview with President and CEO Håkan Lundstedt, together with a presentation of the Q3-results with CFO Per Hedblom. At 10:30 the same day, you will have the opportunity to participate in a live Q&A session, in English.  The interview with CEO and presentation of the Q3-results is video materials created to complement the interim report and provide further insight and better understanding of the company's operations for the

SOFTSWISS Wins SBC Latinoamérica Award for Help Brazil Initiative

SOFTSWISS has won the Socially Responsible Initiative of the Year nomination at the SBC Awards Latinoamérica 2024 for its impactful ‘Help Brazil’  initiative. This recognition underscores the company’s support for Brazilian communities affected by severe flooding earlier this year and its dedication to implementing meaningful social responsibility projects.The SBC Awards Latinoamérica celebrates excellence in the Latin American gaming

Experience the difference with 3Shape Dental System 2024

· Case management speeds up to 10x times faster · Case reloads up to 20x times speedier · Largest and most exciting upgrade in yearsCopenhagen, November 5, 2024 – 3Shape today announces the release of Dental System 2024. The new upgrade brings a huge speedup to Dental System software and case management workflows.   From faster reloads and management of cases to AI-supported workflows that reduce repetitive tasks and manual work, the new Dental System 2024 software delivers extreme productivity for dental labs.    “3Shape Dental System 2024 is a true team effort between dental

BLA for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) accepted for priority review by the U.S. FDA

Stockholm, November 5, 2024: Immedica announces today that the Biologics License Application (BLA) for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) has been successfully validated and accepted for priority review by the U.S. Food and Drug Administration (FDA). Anders Edvell, CEO of Immedica commented: “We are pleased that the FDA has accepted the re-submitted BLA of pegzilarginase and granted priority review. This is a significant step towards providing a much-needed treatment option for patients with ARG1-D in the U.S. For this rare and debilitating condition there

Diamyd Medical and INNODIA partner for Type 1 Diabetes awareness and patient recruitment for the DIAGNODE-3 precision medicine trial

Diamyd Medical has entered a strategic partnership with INNODIA, an international non-profit organization dedicated to advancing research on disease modifying therapies for Type 1 Diabetes. The partnership will leverage INNODIA’s extensive EU-based clinical network with the aim to further amplify patient enrolment and the visibility of the precision medicine Phase 3 trial DIAGNODE-3 ahead of a potential accelerated Biologics Licensing Application in the U.S.“We are delighted to work with INNODIA to spread the awareness of Type 1 Diabetes and Diamyd[®], as well as to ensure that we meet

There are no items matching the current filter
There are no more items matching the current filter
Back to top